Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma

Files

Sonneveld, P.

Zweegman, S.

Cavo, Michele

Nasserinejad, Kazem

Broijl, A.

Troia, R.

Croockewit, A.J. Sandra

Minnema, Monique C.

Boccadoro, Mario